Comparative Risk of Atrial Fibrillation Onset in Statin‐Treated Patients Initiating Icosapent Ethyl and Omega‐3 Acid Ethyl Esters: A Retrospective Cohort Study

Background Icosapent ethyl (IPE) and omega‐3‐acid ethyl esters (docosahexaenoic acid [DHA]/eicosapentaenoic acid [EPA]) are approved as adjunct therapies to statins for reducing cardiovascular events in at‐risk patients. However, concerns remain regarding a potential link between IPE and atrial fibr...

Full description

Saved in:
Bibliographic Details
Main Authors: Jyotirmoy Sarker, Michael Kim, Samantha Patton, Przemysław B. Radwański, Mark A. Munger, Kibum Kim
Format: Article
Language:English
Published: Wiley 2025-08-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.124.038846
Tags: Add Tag
No Tags, Be the first to tag this record!